About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Phase II Study in Patients With Operable Breast Cancer

NCT00518583·9 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Aptium Oncology Research Network

With

Ortho Biotech Products, L.P.

Age

21–any

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Dx of clinical T1c-T3, N0-1, M0 breast cancer
Interval between diagnosis and consent of \<- 62 days
Life expectancy of 10 years
LVEF by MUGA \>= lower limit of normal for the testing facility
Negative serum pregnancy test
Adequate bone marrow, renal, liver function
Negative bone scan
HRT discontinued before study entry
Adequate contraceptive methods

You may not be if

Male breast cancer
Less than 21 years of age
Ulceration, infiltration of the skin, complete fixation or severe skin edema
N3 disease in which nodes are matted and fixed
Suspicious palpable supraclavicular nodes
CT evidence of malignant internal mammary nodes
Pregnancy or breast feeding at time of study entry
Prior therapy for breast cancer
Prior anthracycline for any malignancy
Prior breast malignancy of the contralateral breast
Prior non-breast malignancy within 5 years
Non-malignant disease that would preclude follow up
MI within 6 months, NYHA Class II or greater heart failure
Psychiatric disorders or conditions that would preclude provision of informed consent

The record

StatusUnknown

PhasePhase 2

Taking part30

StartedOct 2006

UpdatedJan 15, 2010

Conditions

Where9

Providence St. Joseph Medical Hospital
Burbank, California, United States
Cedars-Sinai Outpatient Cancer Center
Los Angeles, California, United States
Desert Regional Medical Center Comprehensive Cancer Center
Palm Springs, California, United States

Clareo Health | Phase II Study in Patients With Operable Breast Cancer